Diseases of the Colon & Rectum

, Volume 33, Issue 5, pp 367–369 | Cite as

T-cell subpopulations and colorectal cancer

  • Andrea Ferrara
  • Marvin M. McMillen
  • Garth H. Ballantyne
Original Contributions


Public Health Colorectal Cancer Colorectal Surgery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Champault G. Evaluation par les reactions immunitaires d'hypersensibilitie retardee du risque infectieuse en chirurgie digestive. J Chir 1984;121:203–6.Google Scholar
  2. 2.
    Kronman BS, Shapiro HM, Localio SA. Newer concepts of cancer of the colon and rectum: delayed hypersensitivity responses of patients with carcinoma of the colon and other related tumors. Dis Colon Rectum 1972;15:106–10.PubMedGoogle Scholar
  3. 3.
    Wanebo HJ, Rao B, Attiyeh F, Pinsky C, Middleman P, Stearns M. Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters. Cancer 1980;45:1254–63.PubMedGoogle Scholar
  4. 4.
    Daly JM, Massar E, Giacco G, et al. Parenteral nutrition in esophageal cancer patients. Ann Surg 1982;196:203–8.PubMedGoogle Scholar
  5. 5.
    Brooks DC, Wilmore DW. Nutritional support in the management of colorectal cancer. In: Steele G Jr, Osteen RT, eds. Colorectal cancer: current concepts in diagnosis and treatment. New York: Marcel Dekker, 1989:325–38.Google Scholar
  6. 6.
    Paul WE. The immune system: an introduction. In: Fundamental immunology. New York: Raven Press, 1984;3–22.Google Scholar
  7. 7.
    Reinherz EL, Schlossman SF. Con A-inducible suppression of MLC evidence for mediation by TH2+ T cell subset in man. J Immunol 1979;122:1335–41.PubMedGoogle Scholar
  8. 8.
    Cantor H. T lymphocytes. In: Paul WE, ed. Fundamental immunology. New York: Raven Press, 1984:57–69.Google Scholar
  9. 9.
    Huber B, Cantor H, Shen FW, Boyse EA. Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells: experimental production of mice deprived of T-cell subclasses. J Exp Med 1976;144:1128–33.PubMedGoogle Scholar
  10. 10.
    Cantor H, Boyse EA. Functional subclasses of T lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med 1975;141:1376–89.PubMedGoogle Scholar
  11. 11.
    Dennert G, Yogeeswaran G, Yamagata S. Cloned cell lines with natural killer cell activity, specificity, function, and cell surface markers. J Exp Med 1981;153:545–47.PubMedGoogle Scholar
  12. 12.
    Jones B, Janeway CA Jr. Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature 1981;292:547–9.PubMedGoogle Scholar
  13. 13.
    Yamauchi K, Murphy DB, Cantor H, Gershon RK. Analysis of antigen-specific, Ig-restricted cell-free mataerial made by I-J+ Ly-1 cells (Ly-1 TsiF) that induces Ly2+ cells to express suppressive activity. Eur J Immunol 1981;11:905–12.PubMedGoogle Scholar
  14. 14.
    Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction-specificity, function and responsiveness. Adv Immunol 1979;27:152–77.Google Scholar
  15. 15.
    Trichieri G, Perussia B. Biology of disease: human natural killer cells: biologic and pathologic aspects. Lab Invest 1984;50:489–513.PubMedGoogle Scholar
  16. 16.
    Miller KB, Schwartz RS. Autoimmunity and suppressant T lymphocytes. Adv Intern Med 1982;27:281–313.PubMedGoogle Scholar
  17. 17.
    Abo T, Balch CM. Characterization of HNK-1+ (LEU7) human lymphocytes. III. Interferon effects on spontaneous cytotoxicity and phenotypic expression of lymphocyte subpopulations delineated by the monoclonal HNK-1 antibody. Cell Immunol 1983;73:376–84.Google Scholar
  18. 18.
    Romain PL, Schlossman SF. The T cell circuit: clinical and biological implications. Adv Intern Med 1986;31:1–16.PubMedGoogle Scholar
  19. 19.
    O'Mahony JB, Wood JJ, Rodrick ML, Mannick JA. Changes in T lymphocyte subsets following injury: assessment by flow cytometry and relationship to sepsis. Ann Surg 1985;202:580–6.PubMedGoogle Scholar
  20. 20.
    Polk HC, George CD, Welhausen SR, et al. A systematic study of host defense processes in badly injured man. Ann Surg 1986;204:282–99.PubMedGoogle Scholar
  21. 21.
    Tartter PI. Preoperative lymphocyte subsets and infectious complications after colorectal cancer surgery. Surgery 1988;103:226–30.PubMedGoogle Scholar
  22. 22.
    Balch CM, Tilden AB, Dougherty PA, Cloud GA, Abo T. Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients. Ann Surg 1983;198:192–9.PubMedGoogle Scholar
  23. 23.
    Balch CM, Tilden AB, Dougherty PA, Cloud GA, Abo T. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients. Surgery 1984;95:63–70.PubMedGoogle Scholar
  24. 24.
    Tartter PI, Steinberg B, Barron DM, Martinelli G. The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg 1987;122:1264–8.PubMedGoogle Scholar
  25. 25.
    Bagli DJ, Steele GD Jr, Barlozzari. Natural killer sensitivity of colorectal carcinoma targets. Arch Surg 1989;124:89–93.PubMedGoogle Scholar
  26. 26.
    Fiocchi C. The immunologic resources of the large bowel. In: Kirsner JB, Shorter RG, eds. Diseases of the colon, rectum, and anal canal. Baltimore: Williams & Wilkins, 1988:95–117.Google Scholar
  27. 27.
    Ottaway CA, Bernaerts C, Chan B, Greenberg GR. Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells. Can J Physiol Pharmacol 1983;61:664–71.PubMedGoogle Scholar
  28. 28.
    Payan DG, Brewster DR, Goetz EJ. Specific stimulation of human T lymphocytes by substance P. J Immunol 1983;132:1613–5.Google Scholar
  29. 29.
    Ferrara A, McMillen MA, Schaefer HC, Zucker KA, Goldenring JR, Modlin IM. Cholecystokinin mediated calcium signals in peripheral human blood mononuclear cells. FASEB J 1989;3:A998.Google Scholar
  30. 30.
    Ebert EC, Roberts AI, O'Connell SM, Robertson FM, Nagase H. Characterization of an immunosuppressive factor derived from colon cancer cells. J Immunol 1987;138:2161–8.PubMedGoogle Scholar

Copyright information

© American Society of Colon and Rectal Surgeons 1990

Authors and Affiliations

  • Andrea Ferrara
    • 1
    • 2
  • Marvin M. McMillen
    • 1
  • Garth H. Ballantyne
    • 1
  1. 1.Gastrointestinal Surgery Research Unit, Departments of SurgeryYale University School of Medicine, West Haven VA Medical CenterWest Haven
  2. 2.Bridgeport HospitalBridgeport

Personalised recommendations